RSS Subscribe to our Nanotechnology Business News feed

VivaTome From From Carl Zeiss For Cell Biologists

The VivaTome for fluorescence microscopes from Carl Zeiss is an optimal tool for developmental and cell biologists to examine the dynamics of living specimens without extensive prior know- ledge of optical sectioning.

Oct 17th, 2009

Read more

Cancer Therapeutics Announces Letter of Intent With NanoTherapies, LLC

Cancer Therapeutics, Inc., an emerging biotechnology business incubator with a specific emphasis on disruptive cancer treatments and nanotechnology, announced today it has signed a letter of intent to acquire another 26 percent interest in NanoTherapies, LLC which would give Cancer Therapeutics a total of 51 percent and controlling interest of NanoTherapies.

Oct 16th, 2009

Read more